O	O	0	11	Suppression	Suppression	B-NP	NN	O	0	ROOT	O
O	O	12	14	of	of	B-PP	IN	O	1	NMOD	O
T13	B-Entity	15	22	nuclear	nuclear	B-NP	JJ	B-protein	6	NMOD	B-protein
T13	I-Entity	23	29	factor	factor	I-NP	NN	I-protein	6	NMOD	I-protein
T13	I-Entity	30	35	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T13	I-Entity	36	37	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	38	41	and	and	O	CC	O	12	NMOD	O
T1	B-Protein	42	46	CD18	CD18	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	46	47	-	-	O	HYPH	O	8	P	O
O	O	47	55	mediated	mediate	B-NP	VBN	O	12	NMOD	O
O	O	56	65	leukocyte	leukocyte	I-NP	NN	O	12	NMOD	O
O	O	66	74	adhesion	adhesion	I-NP	NN	O	2	PMOD	O
O	O	75	77	to	to	B-PP	TO	O	1	NMOD	O
O	O	78	81	the	the	B-NP	DT	O	16	NMOD	O
O	O	82	89	corneal	corneal	I-NP	JJ	O	16	NMOD	O
O	O	90	101	endothelium	endothelium	I-NP	NN	O	13	PMOD	O
O	O	102	104	by	by	B-PP	IN	O	1	NMOD	O
O	O	105	118	dexamethasone	dexamethasone	B-NP	NN	O	17	PMOD	O
O	O	118	119	.	.	O	.	O	1	P	O

O	O	121	128	PURPOSE	PURPOSE	B-NP	NN	O	0	ROOT	O
O	O	128	129	:	:	O	:	O	1	P	O
O	O	130	132	To	To	B-VP	TO	O	4	VMOD	O
O	O	133	144	demonstrate	demonstrate	I-VP	VB	O	22	VMOD	O
O	O	145	149	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	150	159	leukocyte	leukocyte	B-NP	NN	O	7	NMOD	O
O	O	160	168	adhesion	adhesion	I-NP	NN	O	13	SUB	O
O	O	169	171	to	to	B-PP	TO	O	7	NMOD	O
O	O	172	180	cultured	culture	B-NP	VBN	B-cell_line	12	NMOD	B-cell_line
O	O	181	188	corneal	corneal	I-NP	NN	I-cell_line	12	NMOD	I-cell_line
O	O	189	200	endothelial	endothelial	I-NP	JJ	I-cell_line	12	NMOD	I-cell_line
O	O	201	206	cells	cell	I-NP	NNS	I-cell_line	8	PMOD	I-cell_line
O	O	207	209	is	be	B-VP	VBZ	O	5	SBAR	O
O	O	210	218	mediated	mediate	I-VP	VBN	O	13	VC	O
O	O	219	221	by	by	B-PP	IN	O	14	VMOD	O
O	O	222	225	the	the	B-NP	DT	O	18	NMOD	O
T2	B-Protein	226	230	CD18	CD18	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	231	238	antigen	antigen	I-NP	NN	I-protein	15	PMOD	I-protein
O	O	238	239	,	,	O	,	O	22	P	O
O	O	240	243	and	and	O	CC	O	22	VMOD	O
O	O	244	246	to	to	B-VP	TO	O	22	VMOD	O
O	O	247	256	determine	determine	I-VP	VB	O	1	NMOD	O
O	O	257	264	whether	whether	B-SBAR	IN	O	22	VMOD	O
O	O	265	278	dexamethasone	dexamethasone	B-NP	NN	O	26	SUB	O
O	O	279	287	directly	directly	B-ADVP	RB	O	26	VMOD	O
O	O	288	298	suppresses	suppress	B-VP	VBZ	O	23	SBAR	O
O	O	299	307	adhesion	adhesion	B-NP	NN	O	26	OBJ	O
O	O	308	310	by	by	B-PP	IN	O	26	VMOD	O
O	O	311	321	inhibiting	inhibit	B-VP	VBG	O	28	PMOD	O
O	O	322	332	activation	activation	B-NP	NN	O	29	OBJ	O
O	O	333	335	of	of	B-PP	IN	O	30	NMOD	O
T14	B-Entity	336	343	nuclear	nuclear	B-NP	JJ	B-protein	35	NMOD	B-protein
T14	I-Entity	344	350	factor	factor	I-NP	NN	I-protein	35	NMOD	I-protein
T14	I-Entity	351	356	kappa	kappa	I-NP	NN	I-protein	35	NMOD	I-protein
T14	I-Entity	357	358	B	B	I-NP	NN	I-protein	31	PMOD	I-protein
O	O	359	360	(	(	O	(	O	38	DEP	O
T15	B-Entity	360	368	NFkappaB	NFkappaB	B-NP	NN	B-protein	38	DEP	B-protein
O	O	368	369	)	)	O	)	O	35	NMOD	O
O	O	369	370	.	.	O	.	O	22	P	O

O	O	371	378	METHODS	METHODS	B-NP	NNS	O	0	ROOT	O
O	O	378	379	:	:	O	:	O	1	P	O
O	O	380	388	Cultured	Culture	B-VP	VBN	O	6	NMOD	O
O	O	389	395	bovine	bovine	B-NP	JJ	O	6	NMOD	O
O	O	396	403	corneal	corneal	I-NP	NN	O	6	NMOD	O
O	O	404	415	endothelium	endothelium	I-NP	NN	O	7	SUB	O
O	O	416	419	was	be	B-VP	VBD	O	1	NMOD	O
O	O	420	430	stimulated	stimulate	I-VP	VBN	O	7	VC	O
O	O	431	434	for	for	B-PP	IN	O	8	VMOD	O
O	O	435	436	6	6	B-NP	CD	O	11	NMOD	O
O	O	437	442	hours	hour	I-NP	NNS	O	9	PMOD	O
O	O	443	445	by	by	B-PP	IN	O	8	VMOD	O
O	O	446	448	40	40	B-NP	CD	O	20	NMOD	O
O	O	449	455	micron	micron	I-NP	NN	O	20	NMOD	O
O	O	455	456	/	/	O	SYM	O	20	P	O
O	O	456	458	ml	ml	B-NP	NN	O	20	NMOD	O
T3	B-Protein	459	464	tumor	tumor	I-NP	NN	B-protein	20	NMOD	B-protein
T3	I-Protein	465	473	necrosis	necrosis	I-NP	NN	I-protein	20	NMOD	I-protein
T3	I-Protein	474	480	factor	factor	I-NP	NN	I-protein	20	NMOD	I-protein
T3	I-Protein	481	486	alpha	alpha	I-NP	NN	I-protein	12	PMOD	I-protein
O	O	487	488	(	(	O	(	O	23	DEP	O
T4	B-Protein	488	496	TNFalpha	TNFalpha	B-NP	NN	B-protein	23	DEP	B-protein
O	O	496	497	)	)	O	)	O	20	NMOD	O
O	O	497	498	.	.	O	.	O	1	P	O

O	O	499	512	Dexamethasone	Dexamethasone	B-NP	NN	O	2	SUB	O
O	O	513	516	was	be	B-VP	VBD	O	0	ROOT	O
O	O	517	522	added	add	I-VP	VBN	O	2	VC	O
O	O	523	524	1	1	B-NP	CD	O	5	NMOD	O
O	O	525	529	hour	hour	I-NP	NN	O	6	PMOD	O
O	O	530	536	before	before	B-PP	IN	O	3	VMOD	O
T5	B-Protein	537	545	TNFalpha	TNFalpha	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	546	557	stimulation	stimulation	I-NP	NN	O	6	PMOD	O
O	O	558	560	in	in	B-PP	IN	O	8	NMOD	O
O	O	561	564	the	the	B-NP	DT	O	12	NMOD	O
O	O	565	578	dexamethasone	dexamethasone	I-NP	NN	O	12	NMOD	O
O	O	579	584	group	group	I-NP	NN	O	9	PMOD	O
O	O	584	585	.	.	O	.	O	2	P	O

O	O	586	591	After	After	B-PP	IN	O	11	VMOD	O
O	O	592	603	stimulation	stimulation	B-NP	NN	O	1	PMOD	O
O	O	603	604	,	,	O	,	O	11	P	O
O	O	605	616	neutrophils	neutrophil	B-NP	NNS	B-cell_type	11	SUB	B-cell_type
O	O	617	626	separated	separate	B-VP	VBN	O	4	NMOD	O
O	O	627	631	from	from	B-PP	IN	O	5	VMOD	O
O	O	632	633	a	a	B-NP	DT	O	10	NMOD	O
O	O	634	641	healthy	healthy	I-NP	JJ	O	9	AMOD	O
O	O	642	647	human	human	I-NP	JJ	O	10	NMOD	O
O	O	648	657	volunteer	volunteer	I-NP	NN	O	6	PMOD	O
O	O	658	662	were	be	B-VP	VBD	O	0	ROOT	O
O	O	663	668	added	add	I-VP	VBN	O	11	VC	O
O	O	669	673	with	with	B-PP	IN	O	12	VMOD	O
O	O	674	676	or	or	B-PP	CC	O	13	PMOD	O
O	O	677	684	without	without	B-PP	IN	O	13	PMOD	O
O	O	685	689	anti	anti	B-NP	AFX	B-protein	19	NMOD	B-protein
O	O	689	690	-	-	I-NP	HYPH	I-protein	19	NMOD	I-protein
T6	B-Protein	690	694	CD18	CD18	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	695	703	antibody	antibody	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	703	704	.	.	O	.	O	11	P	O

O	O	705	708	The	The	B-NP	DT	O	3	NMOD	O
O	O	709	716	culture	culture	I-NP	NN	O	3	NMOD	O
O	O	717	722	plate	plate	I-NP	NN	O	4	SUB	O
O	O	723	726	was	be	B-VP	VBD	O	17	VMOD	O
O	O	727	734	settled	settle	I-VP	VBN	O	4	VC	O
O	O	735	738	for	for	B-PP	IN	O	5	VMOD	O
O	O	739	741	15	15	B-NP	CD	O	8	NMOD	O
O	O	742	749	minutes	minute	I-NP	NNS	O	6	PMOD	O
O	O	750	752	at	at	B-PP	IN	O	5	VMOD	O
O	O	753	755	37	37	B-NP	CD	O	12	NMOD	O
O	O	756	763	degrees	degree	I-NP	NNS	O	12	NMOD	O
O	O	764	765	C	C	I-NP	NN	O	9	PMOD	O
O	O	765	766	,	,	O	,	O	17	P	O
O	O	767	770	and	and	O	CC	O	17	VMOD	O
O	O	771	775	then	then	B-NP	RB	O	17	VMOD	O
O	O	776	787	neutrophils	neutrophil	I-NP	NNS	B-cell_type	17	SUB	B-cell_type
O	O	788	792	were	be	B-VP	VBD	O	0	ROOT	O
O	O	793	802	activated	activate	I-VP	VBN	O	17	VC	O
O	O	803	805	by	by	B-PP	IN	O	18	VMOD	O
O	O	806	807	N	N	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	807	808	-	-	B-NP	HYPH	I-protein	22	P	I-protein
O	O	808	814	formyl	formyl	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	814	815	-	-	B-NP	HYPH	O	24	P	O
O	O	815	824	methionyl	methionyl	I-NP	NN	O	28	NMOD	O
O	O	824	825	-	-	B-NP	HYPH	O	28	P	O
O	O	825	831	leucyl	leucyl	I-NP	NN	O	28	NMOD	O
O	O	831	832	-	-	B-NP	HYPH	O	28	NMOD	O
O	O	832	845	phenylalanine	phenylalanine	I-NP	NN	O	19	PMOD	O
O	O	846	849	for	for	B-PP	IN	O	28	NMOD	O
O	O	850	851	5	5	B-NP	CD	O	31	NMOD	O
O	O	852	859	minutes	minute	I-NP	NNS	O	29	PMOD	O
O	O	859	860	.	.	O	.	O	17	P	O

O	O	861	872	Nonadherent	Nonadherent	B-NP	JJ	O	3	SUB	O
O	O	873	884	neutrophils	neutrophil	I-NP	NNS	B-cell_type	1	NMOD	B-cell_type
O	O	885	889	were	be	B-VP	VBD	O	0	ROOT	O
O	O	890	897	removed	remove	I-VP	VBN	O	3	VC	O
O	O	898	900	by	by	B-PP	IN	O	4	VMOD	O
O	O	901	908	sealing	seal	B-VP	VBG	O	5	PMOD	O
O	O	909	912	and	and	I-VP	CC	O	6	VMOD	O
O	O	913	922	inverting	invert	I-VP	VBG	O	6	VMOD	O
O	O	923	926	the	the	B-NP	DT	O	10	NMOD	O
O	O	927	934	culture	culture	I-NP	NN	O	6	VMOD	O
O	O	935	939	well	well	B-ADVP	RB	O	6	VMOD	O
O	O	939	940	.	.	O	.	O	3	P	O

O	O	941	944	The	The	B-NP	DT	O	3	NMOD	O
O	O	945	958	intracellular	intracellular	I-NP	JJ	O	3	NMOD	O
O	O	959	971	localization	localization	I-NP	NN	O	9	SUB	O
O	O	972	974	of	of	B-PP	IN	O	3	NMOD	O
T16	B-Entity	975	983	NFkappaB	NFkappaB	B-NP	NN	B-protein	4	PMOD	B-protein
O	O	984	989	after	after	B-PP	IN	O	3	NMOD	O
T7	B-Protein	990	998	TNFalpha	TNFalpha	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	999	1009	simulation	simulation	I-NP	NN	O	6	PMOD	O
O	O	1010	1013	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1014	1024	determined	determine	I-VP	VBN	O	9	VC	O
O	O	1025	1027	by	by	B-PP	IN	O	10	VMOD	O
O	O	1028	1036	confocal	confocal	B-NP	JJ	O	13	NMOD	O
O	O	1037	1056	immunocytochemistry	immunocytochemistry	I-NP	NN	O	11	PMOD	O
O	O	1057	1062	using	use	B-VP	VBG	O	13	NMOD	O
O	O	1063	1065	an	an	B-NP	DT	O	19	NMOD	O
O	O	1066	1070	anti	anti	I-NP	AFX	O	19	NMOD	O
O	O	1070	1071	-	-	I-NP	HYPH	O	19	NMOD	O
T8	B-Protein	1071	1074	p65	p65	I-NP	NN	B-protein	19	NMOD	B-protein
O	O	1075	1083	antibody	antibody	I-NP	NN	I-protein	14	OBJ	I-protein
O	O	1083	1084	.	.	O	.	O	9	P	O

O	O	1085	1092	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	O
O	O	1092	1093	:	:	O	:	O	1	P	O
O	O	1094	1104	Neutrophil	Neutrophil	B-NP	NN	B-cell_type	4	NMOD	B-cell_type
O	O	1105	1113	adhesion	adhesion	I-NP	NN	O	10	SUB	O
O	O	1114	1116	to	to	B-PP	TO	O	4	NMOD	O
O	O	1117	1125	cultured	culture	B-NP	VBN	B-cell_line	9	NMOD	B-cell_line
O	O	1126	1133	corneal	corneal	I-NP	NN	I-cell_line	9	NMOD	I-cell_line
O	O	1134	1145	endothelial	endothelial	I-NP	JJ	I-cell_line	9	NMOD	I-cell_line
O	O	1146	1151	cells	cell	I-NP	NNS	I-cell_line	5	PMOD	I-cell_line
O	O	1152	1161	increased	increase	B-VP	VBD	O	1	NMOD	O
O	O	1162	1175	significantly	significantly	B-ADVP	RB	O	10	VMOD	O
O	O	1176	1178	on	on	B-PP	IN	O	10	VMOD	O
O	O	1179	1187	exposure	exposure	B-NP	NN	O	12	PMOD	O
O	O	1188	1190	to	to	B-PP	TO	O	13	NMOD	O
T9	B-Protein	1191	1199	TNFalpha	TNFalpha	B-NP	NN	B-protein	14	PMOD	B-protein
O	O	1200	1201	(	(	O	(	O	13	NMOD	O
O	O	1201	1204	451	451	B-NP	CD	O	19	NMOD	O
O	O	1204	1205	.	.	O	.	O	17	P	O
O	O	1205	1206	4	4	B-NP	CD	O	28	NMOD	O
O	O	1206	1207	+	+	O	SYM	O	21	AMOD	O
O	O	1207	1208	/	/	O	SYM	B-cell_line	19	NMOD	B-cell_line
O	O	1208	1209	-	-	B-NP	SYM	I-cell_line	21	NMOD	I-cell_line
O	O	1209	1211	45	45	B-NP	CD	I-cell_line	22	PRD	I-cell_line
O	O	1211	1212	.	.	O	.	I-cell_line	28	NMOD	I-cell_line
O	O	1212	1213	4	4	B-NP	CD	I-cell_line	26	NMOD	I-cell_line
O	O	1214	1219	cells	cell	I-NP	NNS	I-cell_line	28	NMOD	I-cell_line
O	O	1219	1220	/	/	O	SYM	O	28	NMOD	O
O	O	1220	1223	mm2	mm2	B-NP	NN	O	30	NMOD	O
O	O	1223	1224	,	,	O	,	O	30	P	O
O	O	1225	1226	n	n	B-NP	NN	O	16	PMOD	O
O	O	1227	1228	=	=	B-VP	JJ	O	30	NMOD	O
O	O	1229	1231	16	16	B-NP	CD	O	31	AMOD	O
O	O	1231	1232	)	)	O	)	O	30	NMOD	O
O	O	1233	1241	compared	compare	B-VP	VBN	O	30	NMOD	O
O	O	1242	1244	to	to	B-PP	TO	O	34	VMOD	O
O	O	1245	1252	control	control	B-NP	NN	O	35	PMOD	O
O	O	1253	1254	(	(	O	(	O	60	DEP	O
O	O	1254	1257	156	156	B-NP	CD	O	47	NMOD	O
O	O	1257	1258	.	.	I-NP	.	O	38	P	O
O	O	1258	1259	7	7	I-NP	CD	O	47	NMOD	O
O	O	1259	1260	+	+	B-NP	SYM	O	47	NMOD	O
O	O	1260	1261	/	/	I-NP	SYM	B-cell_line	47	P	B-cell_line
O	O	1261	1262	-	-	I-NP	SYM	I-cell_line	47	NMOD	I-cell_line
O	O	1262	1264	27	27	I-NP	CD	I-cell_line	47	NMOD	I-cell_line
O	O	1264	1265	.	.	I-NP	SYM	I-cell_line	47	NMOD	I-cell_line
O	O	1265	1266	3	3	I-NP	CD	I-cell_line	47	NMOD	I-cell_line
O	O	1267	1272	cells	cell	I-NP	NNS	I-cell_line	49	NMOD	I-cell_line
O	O	1272	1273	/	/	O	SYM	O	49	P	O
O	O	1273	1276	mm2	mm2	B-NP	NN	O	55	NMOD	O
O	O	1276	1277	,	,	O	,	O	55	P	O
O	O	1278	1279	n	n	B-NP	NN	O	55	NMOD	O
O	O	1280	1281	=	=	B-VP	SYM	O	51	NMOD	O
O	O	1282	1284	16	16	B-NP	CD	O	52	AMOD	O
O	O	1284	1285	,	,	O	,	O	55	P	O
O	O	1286	1287	P	P	B-NP	NN	O	60	DEP	O
O	O	1288	1289	<	<	B-VP	SYM	O	55	NMOD	O
O	O	1290	1291	0	0	B-NP	CD	O	56	AMOD	O
O	O	1291	1292	.	.	I-NP	.	O	55	P	O
O	O	1292	1294	01	01	I-NP	CD	O	55	NMOD	O
O	O	1294	1295	)	)	O	)	O	36	NMOD	O
O	O	1295	1296	.	.	O	.	O	1	P	O

O	O	1297	1301	This	This	B-NP	DT	O	3	NMOD	O
O	O	1302	1311	increased	increase	I-NP	VBN	O	3	NMOD	O
O	O	1312	1320	adhesion	adhesion	I-NP	NN	O	4	SUB	O
O	O	1321	1324	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1325	1335	suppressed	suppress	I-VP	VBN	O	4	VC	O
O	O	1336	1338	by	by	B-PP	IN	O	5	VMOD	O
O	O	1339	1342	the	the	B-NP	DT	O	8	NMOD	O
O	O	1343	1351	addition	addition	I-NP	NN	O	6	PMOD	O
O	O	1352	1354	of	of	B-PP	IN	O	8	NMOD	O
O	O	1355	1359	anti	anti	B-NP	AFX	O	13	NMOD	O
O	O	1359	1360	-	-	I-NP	HYPH	O	13	NMOD	O
T10	B-Protein	1360	1364	CD18	CD18	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	1365	1373	antibody	antibody	I-NP	NN	O	9	PMOD	O
O	O	1374	1375	(	(	O	(	O	37	DEP	O
O	O	1375	1378	157	157	B-NP	CD	O	24	NMOD	O
O	O	1378	1379	.	.	O	.	O	15	P	O
O	O	1379	1380	6	6	B-NP	CD	O	24	NMOD	O
O	O	1380	1381	+	+	B-NP	SYM	O	24	NMOD	O
O	O	1381	1382	/	/	I-NP	SYM	B-cell_line	24	NMOD	B-cell_line
O	O	1382	1383	-	-	I-NP	SYM	I-cell_line	24	NMOD	I-cell_line
O	O	1383	1385	25	25	B-NP	CD	I-cell_line	24	NMOD	I-cell_line
O	O	1385	1386	.	.	I-NP	SYM	I-cell_line	24	NMOD	I-cell_line
O	O	1386	1387	1	1	I-NP	CD	I-cell_line	24	NMOD	I-cell_line
O	O	1388	1393	cells	cell	I-NP	NNS	I-cell_line	26	NMOD	I-cell_line
O	O	1393	1394	/	/	O	SYM	O	26	P	O
O	O	1394	1397	mm2	mm2	B-NP	NN	O	32	NMOD	O
O	O	1397	1398	,	,	O	,	O	32	P	O
O	O	1399	1400	n	n	B-NP	NN	O	32	NMOD	O
O	O	1401	1402	=	=	B-VP	SYM	O	28	NMOD	O
O	O	1403	1404	8	8	B-NP	CD	O	29	AMOD	O
O	O	1404	1405	,	,	O	,	O	32	P	O
O	O	1406	1407	P	P	B-NP	NN	O	37	DEP	O
O	O	1408	1409	<	<	B-VP	SYM	O	32	NMOD	O
O	O	1410	1411	0	0	B-NP	CD	O	33	AMOD	O
O	O	1411	1412	.	.	I-NP	.	O	32	P	O
O	O	1412	1414	01	01	I-NP	CD	O	32	NMOD	O
O	O	1414	1415	)	)	O	)	O	13	NMOD	O
O	O	1416	1419	and	and	O	CC	O	6	PMOD	O
O	O	1420	1422	by	by	B-PP	IN	O	6	PMOD	O
O	O	1423	1435	pretreatment	pretreatment	B-NP	NN	O	39	PMOD	O
O	O	1436	1440	with	with	B-PP	IN	O	40	NMOD	O
O	O	1441	1443	10	10	B-NP	CD	O	47	AMOD	O
O	O	1443	1444	(	(	O	(	O	46	DEP	O
O	O	1444	1445	-	-	O	SYM	O	46	DEP	O
O	O	1445	1446	7	7	O	CD	O	44	PRD	O
O	O	1446	1447	)	)	O	)	O	42	NMOD	O
O	O	1448	1449	M	M	B-NP	NN	O	48	NMOD	O
O	O	1450	1463	dexamethasone	dexamethasone	I-NP	NN	O	41	PMOD	O
O	O	1464	1465	(	(	O	(	O	72	DEP	O
O	O	1465	1468	207	207	B-NP	CD	O	59	NMOD	O
O	O	1468	1469	.	.	O	.	O	50	P	O
O	O	1469	1470	9	9	B-NP	CD	O	59	NMOD	O
O	O	1470	1471	+	+	O	SYM	O	59	NMOD	O
O	O	1471	1472	/	/	B-NP	SYM	B-cell_line	59	NMOD	B-cell_line
O	O	1472	1473	-	-	B-NP	SYM	I-cell_line	59	NMOD	I-cell_line
O	O	1473	1475	31	31	B-NP	CD	I-cell_line	58	AMOD	I-cell_line
O	O	1475	1476	.	.	I-NP	SYM	I-cell_line	58	AMOD	I-cell_line
O	O	1476	1477	5	5	I-NP	CD	I-cell_line	59	NMOD	I-cell_line
O	O	1478	1483	cells	cell	I-NP	NNS	I-cell_line	61	NMOD	I-cell_line
O	O	1483	1484	/	/	O	SYM	O	61	P	O
O	O	1484	1487	mm2	mm2	B-NP	NN	O	67	NMOD	O
O	O	1487	1488	,	,	O	,	O	67	P	O
O	O	1489	1490	n	n	B-NP	NN	O	67	NMOD	O
O	O	1491	1492	=	=	B-VP	SYM	O	63	NMOD	O
O	O	1493	1495	10	10	B-NP	CD	O	64	AMOD	O
O	O	1495	1496	,	,	O	,	O	67	P	O
O	O	1497	1498	P	P	B-NP	NN	O	72	DEP	O
O	O	1499	1500	<	<	B-VP	SYM	O	67	NMOD	O
O	O	1501	1502	0	0	B-NP	CD	O	68	AMOD	O
O	O	1502	1503	.	.	I-NP	.	O	67	P	O
O	O	1503	1505	01	01	I-NP	CD	O	67	NMOD	O
O	O	1505	1506	)	)	O	)	O	48	NMOD	O
O	O	1506	1507	.	.	O	.	O	4	P	O

O	O	1508	1527	Immunocytochemistry	Immunocytochemistry	B-NP	NN	O	3	NMOD	O
O	O	1528	1530	60	60	B-NP	CD	O	3	NMOD	O
O	O	1531	1538	minutes	minute	I-NP	NNS	O	6	SUB	O
O	O	1539	1544	after	after	B-SBAR	IN	O	3	NMOD	O
O	O	1545	1556	stimulation	stimulation	B-NP	NN	O	4	PMOD	O
O	O	1557	1565	revealed	reveal	B-VP	VBD	O	24	VMOD	O
O	O	1566	1570	that	that	B-SBAR	IN	O	6	VMOD	O
T17	B-Entity	1571	1579	NFkappaB	NFkappaB	B-NP	NN	B-protein	9	SUB	B-protein
O	O	1580	1583	was	be	B-VP	VBD	O	7	SBAR	O
O	O	1584	1591	located	locate	I-VP	VBN	O	9	PRD	O
O	O	1592	1594	in	in	B-PP	IN	O	10	AMOD	O
O	O	1595	1598	the	the	B-NP	DT	O	13	NMOD	O
O	O	1599	1608	cytoplasm	cytoplasm	I-NP	NN	O	11	PMOD	O
O	O	1609	1611	in	in	B-PP	IN	O	13	NMOD	O
O	O	1612	1624	unstimulated	unstimulated	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	1625	1630	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	1630	1631	;	;	O	:	O	24	P	O
O	O	1632	1639	however	however	B-ADVP	RB	O	24	VMOD	O
O	O	1639	1640	,	,	O	,	O	24	P	O
O	O	1641	1644	the	the	B-NP	DT	O	21	NMOD	O
O	O	1645	1653	addition	addition	I-NP	NN	O	24	SUB	O
O	O	1654	1656	of	of	B-PP	IN	O	21	NMOD	O
T11	B-Protein	1657	1665	TNFalpha	TNFalpha	B-NP	NN	B-protein	22	PMOD	B-protein
O	O	1666	1672	caused	cause	B-VP	VBD	O	0	ROOT	O
T18	B-Entity	1673	1681	NFkappaB	NFkappaB	B-NP	NN	B-protein	27	SUB	B-protein
O	O	1682	1684	to	to	B-VP	TO	O	27	VMOD	O
O	O	1685	1696	translocate	translocate	I-VP	VB	O	24	VMOD	O
O	O	1697	1701	into	into	B-PP	IN	O	27	VMOD	O
O	O	1702	1705	the	the	B-NP	DT	O	30	NMOD	O
O	O	1706	1713	nucleus	nucleus	I-NP	NN	O	28	PMOD	O
O	O	1713	1714	.	.	O	.	O	24	P	O

O	O	1715	1727	Pretreatment	Pretreatment	B-NP	NN	O	4	SUB	O
O	O	1728	1732	with	with	B-PP	IN	O	1	NMOD	O
O	O	1733	1746	dexamethasone	dexamethasone	B-NP	NN	O	2	PMOD	O
O	O	1747	1754	tapered	taper	B-VP	VBD	O	0	ROOT	O
T19	B-Entity	1755	1763	NFkappaB	NFkappaB	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	1764	1777	translocation	translocation	I-NP	NN	O	4	OBJ	O
O	O	1778	1782	into	into	B-PP	IN	O	6	NMOD	O
O	O	1783	1786	the	the	B-NP	DT	O	9	NMOD	O
O	O	1787	1794	nucleus	nucleus	I-NP	NN	O	7	PMOD	O
O	O	1794	1795	.	.	O	.	O	4	P	O

O	O	1796	1807	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	O
O	O	1807	1808	:	:	O	:	O	1	P	O
O	O	1809	1818	Leukocyte	Leukocyte	B-NP	NN	O	4	NMOD	O
O	O	1819	1827	adhesion	adhesion	I-NP	NN	O	9	SUB	O
O	O	1828	1830	to	to	B-PP	TO	O	4	NMOD	O
O	O	1831	1834	the	the	B-NP	DT	O	8	NMOD	O
O	O	1835	1842	corneal	corneal	I-NP	NN	O	8	NMOD	O
O	O	1843	1854	endothelium	endothelium	I-NP	NN	O	5	PMOD	O
O	O	1855	1858	was	be	B-VP	VBD	O	1	NMOD	O
O	O	1859	1864	shown	show	I-VP	VBN	O	9	VC	O
O	O	1865	1867	to	to	I-VP	TO	O	12	VMOD	O
O	O	1868	1870	be	be	I-VP	VB	O	10	VMOD	O
O	O	1871	1879	mediated	mediate	I-VP	VBN	O	12	VC	O
O	O	1880	1882	by	by	B-PP	IN	O	13	VMOD	O
T12	B-Protein	1883	1887	CD18	CD18	B-NP	NN	B-protein	14	PMOD	B-protein
O	O	1888	1897	expressed	express	B-VP	VBN	O	15	NMOD	O
O	O	1898	1900	on	on	B-PP	IN	O	16	VMOD	O
O	O	1901	1910	activated	activate	B-NP	VBN	B-cell_type	19	NMOD	B-cell_type
O	O	1911	1921	leukocytes	leukocyte	I-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	1921	1922	.	.	O	.	O	1	P	O

O	O	1923	1935	Pretreatment	Pretreatment	B-NP	NN	O	7	SUB	O
O	O	1936	1938	of	of	B-PP	IN	O	1	NMOD	O
O	O	1939	1942	the	the	B-NP	DT	O	4	NMOD	O
O	O	1943	1954	endothelium	endothelium	I-NP	NN	O	2	PMOD	O
O	O	1955	1959	with	with	B-PP	IN	O	1	NMOD	O
O	O	1960	1973	dexamethasone	dexamethasone	B-NP	NN	O	5	PMOD	O
O	O	1974	1983	inhibited	inhibit	B-VP	VBD	O	12	VMOD	O
O	O	1984	1993	leukocyte	leukocyte	B-NP	NN	O	9	NMOD	O
O	O	1994	2002	adhesion	adhesion	I-NP	NN	O	7	OBJ	O
O	O	2002	2003	;	;	O	:	O	12	P	O
O	O	2004	2008	this	this	B-NP	DT	O	12	SUB	O
O	O	2009	2012	may	may	B-VP	MD	O	0	ROOT	O
O	O	2013	2015	be	be	I-VP	VB	O	12	VC	O
O	O	2016	2019	due	due	B-ADJP	JJ	O	13	PRD	O
O	O	2020	2022	in	in	B-PP	IN	O	14	AMOD	O
O	O	2023	2027	part	part	B-NP	NN	O	15	PMOD	O
O	O	2028	2030	to	to	B-PP	TO	O	14	AMOD	O
O	O	2031	2034	the	the	B-NP	DT	O	19	NMOD	O
O	O	2035	2046	suppression	suppression	I-NP	NN	O	17	PMOD	O
O	O	2047	2049	of	of	B-PP	IN	O	19	NMOD	O
T20	B-Entity	2050	2058	NFkappaB	NFkappaB	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	2059	2064	entry	entry	I-NP	NN	O	20	PMOD	O
O	O	2065	2069	into	into	B-PP	IN	O	22	NMOD	O
O	O	2070	2073	the	the	B-NP	DT	O	25	NMOD	O
O	O	2074	2081	nucleus	nucleus	I-NP	NN	O	23	PMOD	O
O	O	2081	2082	.	.	O	.	O	12	P	O
